Q-Line Biotech Board to Consider Half-Year Financial Results on 12th Nov'26
Q-Line Biotech Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Q-Line Biotech Board to Consider Half-Year Financial Results on 12th Nov'26 Q-Line Biotech Limited has scheduled a Board of Directors meeting on 12th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the half year ended 30th Sep'26. The board will review the Statement of Assets and Liabilities, Cash Flow statement, and the Statutory Auditor's Limited Review Reports, pursuant to Regulation 29 of SEBI LODR Regulations.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. 路 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Investor Presentation 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about General Updates 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "PRESS RELEASE ON FINANCIAL RESULTS 30 SEPTEMBER 2026.". 路 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
